Federated Hermes, Inc.

Equities

FHI

US3142111034

Investment Management & Fund Operators

Market Closed - Nyse Other stock markets 04:00:02 2024-07-05 pm EDT			5-day change	1st Jan Change
32.57 ^USD	-1.15%		-0.94%	-3.81%

Jun. 04	AstraZeneca AB completed the acquisition of Fusion Pharmaceuticals Inc. from a group of shareholders.	CI
Jun. 03	After trial, investors weigh Trump 2.0 factor as election looms	RE

Federated Hermes, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020

January 28, 2021 at 04:17 pm EST

Federated Hermes, Inc. announced earnings results for the fourth quarter ended December 31, 2020. For the fourth quarter, the company announced total revenue was USD 363.918 million compared to USD 358.025 million a year ago. Operating income was USD 114.775 million compared to USD 102.791 million a year ago. Net income was USD 95.168 million compared to USD 82.107 million a year ago. For the full year, total revenue was USD 1,448.268 million compared to USD 1,326.894 million a year ago. Operating income was USD 418.151 million compared to USD 347.927 million a year ago. Net income was USD 326.364 million compared to USD 272.339 million a year ago.

Latest news about Federated Hermes, Inc.

AstraZeneca AB completed the acquisition of Fusion Pharmaceuticals Inc. from a group of shareholders.	Jun. 03	CI
After trial, investors weigh Trump 2.0 factor as election looms	Jun. 03	RE
Zenas BioPharma, Inc. announced that it has received $200.145732 million in funding from a group of investors	May. 06	CI
Zenas BioPharma, Inc. announced that it expects to receive $200.145732 million in funding	May. 02	CI
RBC Capital Cuts Federated Hermes Price Target to $35 From $37, Maintains Sector Perform Rating	Apr. 29	MT
UBS Adjusts Federated Hermes Price Target to $36 From $39, Maintains Neutral Rating	Apr. 29	MT
Transcript : Federated Hermes, Inc., Q1 2024 Earnings Call, Apr 26, 2024	Apr. 26
Tranche Update on Federated Hermes, Inc.'s Equity Buyback Plan announced on October 26, 2023.	Apr. 25	CI
Federated Hermes, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Earnings Flash (FHI) FEDERATED HERMES Posts Q1 EPS $0.89	Apr. 25	MT
Earnings Flash (FHI) FEDERATED HERMES Posts Q1 Revenue $396.4M	Apr. 25	MT
Federated Hermes, Inc. Declares Special Dividend, Payable on May 15, 2024	Apr. 25	CI
Federated Hermes, Inc. Declares Quarterly Dividend, Payable on May 15, 2024	Apr. 25	CI
Transcript : Federated Hermes, Inc. - Shareholder/Analyst Call	Apr. 25
UBS Adjusts Federated Hermes Price Target to $39 From $37, Maintains Neutral Rating	Apr. 12	MT
EMEA Morning Briefing : Stocks Seen Lower; Investors Await Fresh Data for Rate Cut Cues	Mar. 26	DJ
EMEA Morning Briefing : Stocks May Ease After Record Highs	Mar. 22	DJ
Policy uncertainty drives investors into US medium-term bond funds	Mar. 20	RE
AstraZeneca AB entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc. for $1.8 billion.	Mar. 18	CI
Regulus Therapeutics Inc. announced that it has received $100.000267 million in funding from a group of investors	Mar. 13	CI
Analysis-Property titans seek clues in Cannes for market turnaround	Mar. 13	RE
Federated Hermes Premier Municipal Income Fund Declares Dividend, Payable on April 1, 2024	Mar. 11	CI
Regulus Therapeutics Inc. announced that it expects to receive $100.000267 million in funding from a group of investors	Mar. 10	CI
Federated Hermes Insider Sold Shares Worth $500,327, According to a Recent SEC Filing	Mar. 07	MT
Xcelerate Pte Ltd announced that it has received $25 million in funding from Federated Hermes, Inc., Altair Capital Advisors Pte Ltd, Exacta Capital Partners, and other investors	Feb. 24	CI

Chart Federated Hermes, Inc.

Duration

Period

More charts

Company Profile

Federated Hermes, Inc. is an investment management company. The Company operates through a single segment, being the investment management business. It sponsors, markets and provides investment-related services to various investment products, including sponsored investment companies and other funds (Federated Hermes Funds); and Separate Accounts, which include separately managed accounts (SMAs), institutional accounts, sub-advised funds and other managed products in both domestic and international markets. In addition, it markets and provides stewardship and real estate development services to various domestic and international companies. The Company provides investment advisory services to approximately 180 Federated Hermes Funds. It markets these funds to institutional customers and banks, broker/dealers and other financial intermediaries who use them to meet the needs of customers and/or clients, including, among others, retail investors, corporations and retirement plans.

Sector

Investment Management & Fund Operators

Calendar

2024-07-24 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

INTERVIEW - Linda Duessel, Federated Hermes: US-China tension around AI makes investing in China riskier

September 11, 2023 at 04:48 pm EDT

More Strategies

Ratings for Federated Hermes, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

32.57 USD

Average target price

37.12 USD

Spread / Average Target

+13.99%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Investment Management

	1st Jan change	Capi.
FEDERATED HERMES, INC.	-3.81%	2.61B
BLACKSTONE INC.	-6.26%	93.17B
ARES MANAGEMENT CORPORATION	+16.26%	27.54B
LEGAL & GENERAL PLC	-7.49%	17.56B
THE CARLYLE GROUP INC.	-0.98%	14.5B
AMUNDI	+4.38%	14.16B
FRANKLIN RESOURCES, INC.	-25.85%	11.62B
HDFC ASSET MANAGEMENT COMPANY LIMITED	+32.13%	10.83B
BLUE OWL CAPITAL INC.	+18.72%	9.21B
LUMINE GROUP INC.	+23.44%	6.95B

Investment Management